August 26, 2025

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a Potential 33% Upside Amidst Strong Analyst Ratings

NeoGenomics, Inc. (NASDAQ: NEO), a leader in the healthcare sector specializing in diagnostics and research, is capturing investor attention with a notable potential upside of 33.51%, according to recent analyst..

Xenon Pharmaceuticals Inc. (XENE): Analyst Consensus Reveals 43.92% Potential Upside in Neuroscience Biotech

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a prominent player in the biotechnology sector, is capturing attention with its promising pipeline in neuroscience therapeutics and a compelling 43.92% potential upside based on..

Biohaven Ltd. (BHVN) Stock Analysis: A Look at the 215% Potential Upside

Biohaven Ltd. (NASDAQ: BHVN), a dynamic player in the healthcare sector specializing in biotechnology, is capturing investors’ attention with its impressive 215.55% potential upside. With a market cap of $1.58..

Opko Health, Inc. (OPK)

⚠️ No article content returned.

..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Unpacking the 243% Upside Potential

Viking Therapeutics, Inc. (NASDAQ: VKTX), a dynamic player in the biotechnology sector, is capturing the attention of investors with its innovative approach to treating metabolic and endocrine disorders. Headquartered in..

Ligand Pharmaceuticals (LGND) Stock Analysis: Unpacking the 5.33% Potential Upside

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a dynamic player in the biotechnology sector, has piqued investor interest with a 5.33% potential upside according to current analyst ratings. With a market capitalization..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring a 22.59% Potential Upside

For investors keeping a close eye on the biotechnology sector, Protagonist Therapeutics, Inc. (NASDAQ: PTGX) presents a compelling opportunity with a notable potential upside of 22.59%. Headquartered in Newark, California,..

Mesoblast Limited (MESO) Stock Analysis: Unlocking 71.87% Potential Upside

Mesoblast Limited (MESO), a prominent player in the biotechnology sector, is gaining attention from investors due to its significant potential upside. With a market capitalization of $2.03 billion, this Australian..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Strong Buy Ratings Amid Rapid Revenue Growth

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has garnered significant attention from investors, thanks to its robust revenue growth and promising analyst ratings. As a biopharmaceutical company, ANI Pharmaceuticals develops, manufactures, and..

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare with a 3.27% Dividend Yield

Premier, Inc. (NASDAQ: PINC), a key player in the healthcare sector, finds itself at an intriguing juncture, presenting both challenges and opportunities for potential investors. Based in Charlotte, North Carolina,..

MiMedx Group, Inc. (MDXG) Stock Analysis: A Promising 72% Upside in the Biotech Space

MiMedx Group, Inc. (NASDAQ: MDXG), a notable player in the biotechnology sector, has been attracting attention with its innovative healthcare solutions. Specializing in the development and distribution of placental tissue..

SpringWorks Therapeutics, Inc. (SWTX): Investor Outlook Highlights Revenue Growth and Market Position

SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) has been making waves in the biotechnology sector with its focused approach on developing treatments for rare diseases and cancer. With a current market capitalization..

Haemonetics Corporation (HAE) Stock Analysis: A 42% Upside Potential in the Healthcare Sector

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector, stands at a pivotal point for investors seeking robust growth in the medical devices industry. With a current market..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Challenges with 8.78% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a key player in the U.S. healthcare sector, operates as a prominent provider of senior living solutions. Specializing in Independent Living, Assisted Living and..

Novavax, Inc. (NVAX) Stock Analysis: Exploring Its 70.97% Potential Upside

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, has captured the attention of investors with its innovative approach to vaccine development. Based in Gaithersburg, Maryland, Novavax is..

Merus N.V. (MRUS) Stock Analysis: A Biotech with 37.47% Potential Upside

Merus N.V. (NASDAQ: MRUS), a Dutch clinical-stage biotechnology company, is capturing investor attention with its promising pipeline of antibody therapeutics and a significant potential upside of 37.47%. As a key..

Evotec SE (EVO) Stock Analysis: Uncovering a 60% Potential Upside Amidst Innovative Collaborations

Investors with a keen eye on the healthcare sector may want to consider Evotec SE (EVO), a promising player in the drug discovery and development landscape. With its headquarters in..

MannKind Corporation (MNKD) Stock Analysis: A 149% Upside and Strong Buy Ratings Propel Investor Interest

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology sector, has become a focal point for investors due to its robust potential upside and unanimous buy ratings from analysts...

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Healthcare Innovator with 7.35% Potential Upside

LeMaitre Vascular, Inc. (LMAT) is an intriguing player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Burlington, Massachusetts, this company has carved a niche..

GRAIL, Inc. (GRAL) Stock Analysis: Exploring a 23% Potential Upside in the Diagnostics Sector

For investors keen on the healthcare sector, particularly within diagnostics and research, GRAIL, Inc. (NASDAQ: GRAL) offers a compelling proposition. With its current price standing at $32.925 and a potential..

Search

Funds

August 26, 2025

Search

Funds

August 26, 2025

FTSE 100

Funds